Indiscriminate use of plasma method is not appropriate in the treatment of Kovid-19 patients: ICMR
New Delhi: Indian Council of Medical Research (ICMR) has issued a consultation saying that indiscriminate use of plasma method is not appropriate in the treatment of Kovid-19 patients. In this method, the plasma of the cured patients by beating the epidemic is used in the treatment of other patients.
Meanwhile, the total number of corona virus infections in India has crossed 89 million. The country’s top health research unit has said in an evidence-based consultation on the improper use of the plasma method that plasma donors must have sufficient concentrations of antibodies that act against Kovid-19 in their bodies.
Improvement in therapeutic outcomes, severity of disease, length of hospital stay, and reduction in mortality depend on the concentrations of specific antibodies in plasma that may eliminate the effects of SARS-Cove-2. This method has previously been used in the treatment of viral infections such as H1N1, Ebola and SARS-Cove-1.
The ICMR recently said after a study in 39 private and government hospitals that the plasma method is not proving to be effective in treating severe patients with corona virus infection and reducing mortality. The consultation states that similar studies were conducted in China and the Netherlands, which did not see any significant benefit of this method.
It states that indiscriminate use of plasma method is not appropriate in the treatment of patients with corona virus infection. Specific antibodies with low concentrations against SARS-Cove-2 are said to be less beneficial than antibodies to higher concentrations in the treatment of COVID-19 patients.
The consultation states that therefore a potential donor of plasma must have sufficient concentrations in antibodies that act against Kovid-19 in the body. It states that this method should be used only in accordance with ICMR’s consultation on the completion of specific standards. (Agency)